3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Becker Muscular Dystrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Khalidi, R; Ambati, J; Ambati, K; Arkle, S; Bruno, C; Chira, N; Cox, P; Gazzerro, E; Górecki, DC; McGeehan, RE; Panicucci, C; Róg, J; Young, CNJ; Zabłocki, K | 1 |
1 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Becker Muscular Dystrophy
Article | Year |
---|---|
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
Topics: Adenosine Triphosphate; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites; Calcium; Cells, Cultured; Collagen Type IV; Creatine Kinase; Disease Models, Animal; Male; Mice; Mice, Inbred mdx; Mice, Transgenic; Models, Molecular; Muscle Strength; Muscles; Muscular Dystrophy, Duchenne; Myoblasts; Receptors, Purinergic P2X7; Zidovudine | 2018 |